Hiroshi Kida

4.8k total citations
173 papers, 3.0k citations indexed

About

Hiroshi Kida is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Nephrology. According to data from OpenAlex, Hiroshi Kida has authored 173 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 38 papers in Epidemiology and 31 papers in Nephrology. Recurrent topics in Hiroshi Kida's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Renal Diseases and Glomerulopathies (29 papers) and Mycobacterium research and diagnosis (20 papers). Hiroshi Kida is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Renal Diseases and Glomerulopathies (29 papers) and Mycobacterium research and diagnosis (20 papers). Hiroshi Kida collaborates with scholars based in Japan, United States and United Kingdom. Hiroshi Kida's co-authors include Isao Tachibana, Hitoshi Yokoyama, Atsushi Kumanogoh, Yoshito Takeda, Nobutaka Hattori, Sho Goya, Ichiro Kawase, Izumi Nagatomo, Tadashi Osaki and Masahide Mori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Hiroshi Kida

163 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hiroshi Kida 872 695 657 615 564 173 3.0k
Norihiko Sakai 758 0.9× 1.2k 1.7× 805 1.2× 428 0.7× 1.0k 1.8× 110 3.7k
Naotake Tsuboi 457 0.5× 585 0.8× 1.3k 2.0× 327 0.5× 951 1.7× 114 3.3k
Yuh Fukuda 1.5k 1.7× 371 0.5× 323 0.5× 484 0.8× 720 1.3× 137 3.7k
Jean‐Michel Goujon 407 0.5× 659 0.9× 505 0.8× 274 0.4× 846 1.5× 83 2.6k
Yasunori Iwata 332 0.4× 1.2k 1.7× 916 1.4× 329 0.5× 754 1.3× 118 3.1k
Giuseppe Castellano 875 1.0× 1.4k 2.0× 1.6k 2.4× 538 0.9× 1.3k 2.3× 190 5.2k
Chang‐Keun Lee 479 0.5× 319 0.5× 621 0.9× 305 0.5× 574 1.0× 175 2.7k
Gianna Mazzucco 553 0.6× 1.4k 2.0× 366 0.6× 175 0.3× 584 1.0× 109 3.1k
Jason Jungsik Song 722 0.8× 214 0.3× 468 0.7× 307 0.5× 695 1.2× 215 2.7k
Udo Helmchen 942 1.1× 2.1k 3.1× 949 1.4× 538 0.9× 1.1k 1.9× 110 4.8k

Countries citing papers authored by Hiroshi Kida

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Kida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kida more than expected).

Fields of papers citing papers by Hiroshi Kida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Kida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kida. The network helps show where Hiroshi Kida may publish in the future.

Co-authorship network of co-authors of Hiroshi Kida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kida. A scholar is included among the top collaborators of Hiroshi Kida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kida. Hiroshi Kida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ozawa, Taijiro, Takanori Asakura, Kozo Morimoto, et al.. (2025). Predictors of Exacerbation of Japanese Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease: A Multicenter Prospective Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7273–A7273.
2.
Hosono, Yuki, Eri Ishikawa, Masatomo Takahashi, et al.. (2024). Identification of α-galactosylceramide as an endogenous mammalian antigen for iNKT cells. The Journal of Experimental Medicine. 222(2). 5 indexed citations
3.
Hashimoto, Kazuki, Yuko Abe, Kiyoharu Fukushima, et al.. (2024). Epidemiology of bronchiectasis at a single center in Japan: a retrospective cohort study. BMC Pulmonary Medicine. 24(1). 531–531.
4.
Hashimoto, Kazuki, Takuro Nii, M. Yokoyama, et al.. (2023). Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report. Infection and Drug Resistance. Volume 16. 6629–6634. 2 indexed citations
5.
Niitsu, Takayuki, Kiyoharu Fukushima, Sho Komukai, et al.. (2023). Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease. RMD Open. 9(1). e002667–e002667. 5 indexed citations
6.
Iwahori, Kota, Takuro Nii, Takahiro Kawasaki, et al.. (2023). A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19. Scientific Reports. 13(1). 13809–13809. 1 indexed citations
7.
Arai, Toru, Masaki Hirose, Tomoko Kagawa, et al.. (2022). Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis. Canadian Respiratory Journal. 2022. 1–10. 3 indexed citations
8.
Arai, Toru, Hiroto Matsuoka, Masaki Hirose, et al.. (2021). Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin. BMJ Open Respiratory Research. 8(1). e000889–e000889. 3 indexed citations
9.
Arai, Toru, Hiroshi Kida, Yoshitaka Ogata, et al.. (2020). Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial. BMJ Open Respiratory Research. 7(1). e000558–e000558. 4 indexed citations
10.
Hara, Reina, Seigo Kitada, Tomoki Kuge, et al.. (2020). Diagnostic Validity of Gastric Aspirate Culture in Nontuberculous Mycobacterial Pulmonary Disease. Annals of the American Thoracic Society. 17(12). 1536–1541. 2 indexed citations
11.
Arai, Toru, Hiroshi Kida, Yoshitaka Ogata, et al.. (2019). Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias. Respirology. 24(7). 658–666. 10 indexed citations
12.
Kida, Hiroshi. (2016). Exhaled Breath Analysis for Lung Cancer. Journal of the Japan Society for Precision Engineering. 82(8). 718–721. 3 indexed citations
13.
Minami, Toshiyuki, Takashi Kijima, Yasushi Otani, et al.. (2012). HER2 As Therapeutic Target for Overcoming ATP-Binding Cassette Transporter–Mediated Chemoresistance in Small Cell Lung Cancer. Molecular Cancer Therapeutics. 11(4). 830–841. 24 indexed citations
14.
Takahashi, Ryo, Haruhiko Hirata, Isao Tachibana, et al.. (2011). Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung. Clinical Cancer Research. 18(1). 220–228. 78 indexed citations
15.
Tetsumoto, Satoshi, Akio Osa, Takashi Kijima, et al.. (2011). Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib. International Journal of Clinical Oncology. 17(2). 155–159. 14 indexed citations
16.
Tanaka, Kõji, Shoji Matsumoto, Hiroshi Kida, et al.. (2010). Lingual angioedema after rt-PA thrombolysis for acute cardioembolic stroke: A case report. Nosotchu. 32(3). 296–300. 1 indexed citations
17.
Suzuki, Mayumi, Isao Tachibana, Yoshito Takeda, et al.. (2009). Tetraspanin CD9 Negatively Regulates Lipopolysaccharide-Induced Macrophage Activation and Lung Inflammation. The Journal of Immunology. 182(10). 6485–6493. 70 indexed citations
18.
Abo, Masahiro, et al.. (1999). BECLOMETHASONE DIPROPRIONATE INHALATION AS A TREATMENT FOR POST‐INTUBATION TRACHEAL STENOSIS. International Journal of Clinical Practice. 53(3). 217–218. 6 indexed citations
19.
Takeda, Shin’ichi, et al.. (1992). Two distinct types of crescentic glomerulonephritis.. PubMed. 37(6). 285–93. 10 indexed citations
20.
Kida, Hiroshi, et al.. (1987). A COMPARATIVE STUDY OF NON-SURGICAL TREATMENT AND SURGICAL TREATMENT OF COMPLETE TEARS OF THE ROTATOR CUFF. 11(1). 113–116. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norihiko Sakai Breakdown of academic impact, for papers by Naotake Tsuboi Breakdown of academic impact, for papers by Yuh Fukuda Breakdown of academic impact, for papers by Jean‐Michel Goujon Breakdown of academic impact, for papers by Yasunori Iwata Breakdown of academic impact, for papers by Giuseppe Castellano Breakdown of academic impact, for papers by Chang‐Keun Lee Breakdown of academic impact, for papers by Gianna Mazzucco Breakdown of academic impact, for papers by Jason Jungsik Song Breakdown of academic impact, for papers by Udo Helmchen
Rankless by CCL
2026